Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?
Autor: | Karer M; Department of Clinical Pharmacology., Stiasny K; Center for Virology, Medical University of Vienna, Vienna, Austria., Zeitlinger M; Department of Clinical Pharmacology., Jilma B; Department of Clinical Pharmacology. |
---|---|
Jazyk: | angličtina |
Zdroj: | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2021 Sep 01; Vol. 32 (6), pp. 423-424. |
DOI: | 10.1097/MBC.0000000000001048 |
Databáze: | MEDLINE |
Externí odkaz: |